臺灣健保癌症用藥事前審查實作指引
1.0.9 - ci-build

臺灣健保癌症用藥事前審查實作指引, published by 衛生福利部中央健康保險署. This guide is not an authorized publication; it is the continuous build for version 1.0.9 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TWNHIFHIR/pas/ and changes regularly. See the Directory of published versions

Example Observation: 病人狀態評估-CTCAE

狀態：final

病人狀態評估項目代碼：The common terminology criteria for adverse events(CTCAE) (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #711434002)

病人：Patient/pat-min

病人狀態評估日期：2025-01-01

評估項目醫事人員身分證號：Practitioner/pra-min

病人狀態評估結果：

CTCAE項目：Hearing impaired (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143528)

value：grade3

CTCAE項目：Peripheral motor neuropathy (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143750)

value：grade4

CTCAE項目：Peripheral sensory neuropathy (LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 #C143752)

value：grade5